/
/
/

Nath Bio-Genes (India) Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)154.00
Volume (₹)6,201.00
High (₹)154.94
Upper Circuit183.68
Low (₹)151.66
Lower Circuit122.46
Prev Close153.07
52W High (₹)204.00
Price153.05
52W Low (₹)126.15

Share Market Cap & Key Ratios Overview

M.Cap (₹)292.57 Cr
Div. Yield (%)1.30
PE Ratio7.99
Debt to Equity0.19
Price to Book0.43
Book Value339.08
EPS (TTM)19.26
Face Value10.00
ROE (%)6.15

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
KSCLNSE
VENKEYSNSE
AVTNPLNSE
FRESHARA-STNSE
BSHSLNSE
REGAALNSE
MGEL-BENSE
SHEETAL-SMNSE
KOTYARK-BENSE
NATHBIOGENNSE
LTP
1W Low
1W High
Market cap (₹)
742.8-44 (-5.59%)
735.95
790
3,837Cr
1655.5+83.6 (5.32%)
1575.40
1747.40
2,362Cr
91.08+5.89 (6.91%)
84.60
97
1,394Cr
423.05-15.85 (-3.61%)
417.80
477.95
1,033Cr
93+1.15 (1.25%)
88.10
94.20
931Cr
88.01-4.5 (-4.86%)
85.45
94.47
919Cr
14.22-0.23 (-1.59%)
13.90
14.75
477Cr
348.1+8.3 (2.44%)
332
352
408Cr
33.76-1.04 (-2.99%)
30.05
34.34
364Cr
153.05-4.25 (-2.70%)
151.66
160.39
293Cr

Key Highlights of Nath Bio-Genes (India) Ltd Balance Sheet

Nath Bio-Genes (India) Ltd balance sheet discloses shareholders' funds of ₹19Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹19Cr, and the reserves and surplus of the company is ₹629.66Cr.

The company has its non-current liabilities with total liabilities of ₹1016.87Cr as of 2025-03-31.

The current liabilities are ₹363.05Cr as of 2025-03-31. At the same time, current assets are ₹680.55Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of ₹6.05Cr and tangible assets of ₹250.22Cr, provided in the Nath Bio-Genes (India) Ltd financial statements.